EP Patent

EP2813224A1 — Prophylactic or therapeutic agent for idiopathic inflammatory myopathies

Assigned to Tokyo Medical and Dental University NUC · Expires 2014-12-17 · 11y expired

What this patent protects

The present invention aims to provide a prophylactic or therapeutic agent for idiopathic inflammatory myopathy or idiopathic inflammatory myopathy associated with steroid-induced myopathy that develops during the course of treatment. The present invention provides a prophyl…

USPTO Abstract

The present invention aims to provide a prophylactic or therapeutic agent for idiopathic inflammatory myopathy or idiopathic inflammatory myopathy associated with steroid-induced myopathy that develops during the course of treatment. The present invention provides a prophylactic or therapeutic agent for idiopathic inflammatory myopathy or idiopathic inflammatory myopathy associated with steroid-induced myopathy that develops during the course of treatment, which contains isoleucine, leucine and valine as active ingredients.

Drugs covered by this patent

Patent Metadata

Patent number
EP2813224A1
Jurisdiction
EP
Classification
—
Expires
2014-12-17
Drug substance claim
No
Drug product claim
No
Assignee
Tokyo Medical and Dental University NUC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.